Document 2755 DOCN M94A2755 TI Belgian multicentre quality control on the performance of selected primer sets for diagnostic HIV-1 PCR. Belgian AIDS Reference Laboratories. DT 9412 AU Vandamme AM; Fransen K; Burtonboy G; Debaisieux L; Marissens D; Rega Institute, Leuven, Belgium. SO Int Conf AIDS. 1994 Aug 7-12;10(1):232 (abstract no. PB0359). Unique Identifier : AIDSLINE ICA10/94369820 AB To evaluate the performance of their diagnostic HIV-1 DNA PCR, 8 Belgian AIDS Reference Laboratories established a multicentre quality control. The centres tested a set of Belgian and African patient samples, collected in Belgium, and the British Medical Research Council (MRC) HIV-1 PCR reference reagent kit, containing plasmid HIV-1 DNA at several dilutions in human carrier DNA with appropriate negative controls. No false positive results were reported. All centres proved to be able to detect 1 to 2 copies of HIV-1 DNA. Among the 17 Belgian and African HIV-1 seropositives, some centres reported up to 4 indeterminate results, mainly due to failure of the SK38-39, SK68-69 (Ou et al. 1988) and/or gag881-882 (Simmonds et al. 1990) primers and to a bad performing algorithm. Only the H1POL4235-4538 nested pol primer set, developed by one of the centres, correctly identified the tested HIV-1 positive and negative samples. To improve their performance, the centres decided to evaluate these pol primers as a reference primer set and to standardize the testing algorithm. On 10 additional Belgian and African patient samples, all centres achieved a sensitivity and specificity of 100% when adapting a standardized algorithm based on 3 HIV-1 primer sets, one of which is the H1POL4235-4538 primer set. DE Africa Algorithms Belgium Comparative Study DNA Primers/*STANDARDS DNA, Viral/*ANALYSIS/GENETICS False Positive Reactions Genes, gag Genes, pol Human HIV Infections/MICROBIOLOGY HIV-1/GENETICS/*ISOLATION & PURIF Polymerase Chain Reaction/*STANDARDS Quality Control Reagent Kits, Diagnostic Reference Standards Sensitivity and Specificity MEETING ABSTRACT MULTICENTER STUDY SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).